@thetelegraph: Scientists believe results from a clinical trial of Lecanemab could signal “the beginning of the end” for those suffering with early Alzheimer’s disease. Here is everything we know so far about the dementia treatment. #health #alzheimersawareness #alzheimersdisease #dementia #dementiaawareness #healthtok #pharmacytiktok #fyp #news #needtoknow #newsexplained #newstok #journotok #memory #memoryloss